Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)

Clinical trial NCT07488754 · RECRUITING

Trial details

NCT number: NCT07488754
Sponsor: Medical University of Warsaw
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Glioblastoma High-Grade Glioma (WHO III-IV)Glioblastoma (GBM)

Start date: 2025-10-01
Primary completion: 2027-09-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.